Cromos Pharma, where the patients are

Europe

Athera Biotechnologies awarded collaborative research grant

Monday, June 17, 2013 01:45 PM

Athera Biotechnologies said future development costs of its fully human antibody PC-mAb, until proof-of-concept, will be co-funded by the European Union’s Seventh Framework Program for Research (FP7) through a collaborative research grant.

More... »

CRF Health eCOA webinar series

Icon, University College Dublin launch graduate certificate in clinical research

Monday, June 17, 2013 01:43 PM

Iconand the University College Dublin (UCD) School of Medicine & Medical Science have launched a graduate certificate in clinical research.

More... »


ExpreS2ion Biotechnologies, Cancer Research U.K. enter license agreement

Monday, June 10, 2013 11:35 AM

ExpreS2ion Biotechnologies has signed a research license agreement to provide the Protein Purification Facility at Cancer Research U.K.’s London Research Institute with access to its Drosophila Schneider-2 cell-based technology platform—ExpreS2—for protein production.

More... »

Cenix BioScience, Debiopharm Group to identify predictive biomarkers

Wednesday, May 29, 2013 10:47 AM

Cenix BioScience, a preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a global Swiss biopharmaceutical group of companies focused on prescription drugs that target unmet medical needs, including oncology and companion diagnostics, have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

More... »

PRA opens new facility in Wales, creates 100 graduate-level jobs

Friday, May 17, 2013 02:03 PM

PRA, a global CRO, has officially opened its new facility in Swansea, Wales. The expansion is being supported with $1.9 million business finance from the Welsh government.

More... »

Bayer to acquire Steigerwald Arzneimittelwerk

Friday, May 17, 2013 11:56 AM

Bayer has signed an agreement to acquire 100% of the shares of Steigerwald Arzneimittelwerk, a Darmstadt, Germany-based privately held pharmaceutical company specializing in pharmacy-only herbal medicines.

More... »

Chiltern appoints Niewel and Bull to senior positions

Thursday, May 16, 2013 08:00 AM

Chiltern International, a global CRO based in the U.K., has appointed Dr. Manuela Niewel as medical director and Lisa Bull as director of strategic partnerships.

More... »

Aesica, University of Nottingham to develop novel amide chemical synthesis technique

Wednesday, May 8, 2013 11:36 AM

Aesica, a global contract manufacturing organization, has formed a partnership with the University of Nottingham for the commercial development of alternative methods in amide bond synthesis.

More... »

EMA publishes initial list of medicines under additional monitoring

Friday, April 26, 2013 10:22 AM

The European Medicines Agency has published the initial list of medicines that are subject to additional monitoring, representing an important deliverable of the new European pharmacovigilance legislation.

More... »

MHRA prioritizes science and research support as part of new corporate plan

Wednesday, April 24, 2013 10:17 AM

The Medicines and Healthcare Products Regulatory Agency (MHRA) announced its aim to be a leading regulator on the world stage in supporting science and research as part of its new five-year corporate plan.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs